Author
Listed:
- Benoit Bilanges
(University College London)
- Samira Alliouachene
(University College London)
- Wayne Pearce
(University College London)
- Daniele Morelli
(University College London)
- Gyorgy Szabadkai
(University College London
University of Padua)
- Yuen-Li Chung
(The Institute of Cancer Research London)
- Gaëtan Chicanne
(Institut des Maladies Métaboliques et Cardiovasculaires)
- Colin Valet
(Institut des Maladies Métaboliques et Cardiovasculaires)
- Julia M. Hill
(University College London)
- Peter J. Voshol
(MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science)
- Lucy Collinson
(Lincoln’s Inn Fields Laboratories)
- Christopher Peddie
(Lincoln’s Inn Fields Laboratories)
- Khaled Ali
(University College London)
- Essam Ghazaly
(Queen Mary University of London)
- Vinothini Rajeeve
(Queen Mary University of London)
- Georgios Trichas
(University of Oxford)
- Shankar Srinivas
(University of Oxford)
- Claire Chaussade
(University College London)
- Rachel S. Salamon
(Albert Einstein College of Medicine)
- Jonathan M. Backer
(Albert Einstein College of Medicine)
- Cheryl L. Scudamore
(Harwell Science and Innovation Campus)
- Maria A. Whitehead
(University College London)
- Erin P. Keaney
(Novartis Institutes for BioMedical Research)
- Leon O. Murphy
(Novartis Institutes for BioMedical Research)
- Robert K. Semple
(University of Cambridge, Addenbrooke’s Hospital)
- Bernard Payrastre
(Institut des Maladies Métaboliques et Cardiovasculaires)
- Sharon A. Tooze
(Lincoln’s Inn Fields Laboratories)
- Bart Vanhaesebroeck
(University College London)
Abstract
Vps34 PI3K is thought to be the main producer of phosphatidylinositol-3-monophosphate, a lipid that controls intracellular vesicular trafficking. The organismal impact of systemic inhibition of Vps34 kinase activity is not completely understood. Here we show that heterozygous Vps34 kinase-dead mice are healthy and display a robustly enhanced insulin sensitivity and glucose tolerance, phenotypes mimicked by a selective Vps34 inhibitor in wild-type mice. The underlying mechanism of insulin sensitization is multifactorial and not through the canonical insulin/Akt pathway. Vps34 inhibition alters cellular energy metabolism, activating the AMPK pathway in liver and muscle. In liver, Vps34 inactivation mildly dampens autophagy, limiting substrate availability for mitochondrial respiration and reducing gluconeogenesis. In muscle, Vps34 inactivation triggers a metabolic switch from oxidative phosphorylation towards glycolysis and enhanced glucose uptake. Our study identifies Vps34 as a new drug target for insulin resistance in Type-2 diabetes, in which the unmet therapeutic need remains substantial.
Suggested Citation
Benoit Bilanges & Samira Alliouachene & Wayne Pearce & Daniele Morelli & Gyorgy Szabadkai & Yuen-Li Chung & Gaëtan Chicanne & Colin Valet & Julia M. Hill & Peter J. Voshol & Lucy Collinson & Christoph, 2017.
"Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism,"
Nature Communications, Nature, vol. 8(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01969-4
DOI: 10.1038/s41467-017-01969-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01969-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.